High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.6M
$2,581,492
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-02 | $286,715 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Krainer Adrian R.
• Director
10b5-1 SellΔOwn -11.1%
2025-11-24
$1,202,719Large
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -11.1%
|
2025-11-24 | $1,202,719Large | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Krainer Adrian R.
• Director
10b5-1 Sell
2025-11-14
$1,092,058Largex2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-11-14 | $1,092,058Largex2 | S | Form 4 |